Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

DEVELOPMENT OF AN ALGORITHM FOR FORMATION OF A PLASMA DONOR BASE FOR PRODUCING A STANDARD SAMPLE OF ANTI-D ANTIBODY

DOI: https://doi.org/10.29296/25877313-2021-08-02
Download full text PDF
Issue: 
8
Year: 
2021

N.S. Vildanova Junior Research Scientist, Blood products laboratory, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: nikulina@niigpk.ru E.S. Kormshchikova Junior Research Scientist, Blood Products Laboratory, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: kormschikova@niigpk.ru E.V. Butina Dr.Sc. (Med.), Head of the Laboratory of Immunohematology, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: butina@niigpk.ru E.A. Poponina Ph.D. (Med.), Research Scientist, Laboratory of Immunohematology, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: poponinaea@niigpk.ru A.V. Yovdiy Ph.D. (Med.), Research Scientist, Laboratory of Immunohematology, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: yovdiy@niigpk.ru F.S. Sherstnev Ph.D. (Med.), Head of the Department of Transfusion and Processing of Hematopoietic Blood Stem Cells, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E -mail: sherstnev@niigpk.ru K.A. Vorobiev Dr.Sc. (Biol.), Deputy Director for Research, the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: vorobiev@niigpk.ru I.V. Paramonov Dr.Sc. (Med.), Director of the Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood Transfusion under the Federal Medical Biological Agence (Kirov, Russia) E-mail: paramonov@niigpk.ru; E.Yu. Kudasheva Ph.D. (Med.), Head of the Laboratory of Immunoglobulins and Blood Products, the Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation (Moscow, Russia) E-mail: kudasheva@expmed.ru A.N. Tarasov Head physician, the Kirov Regional State-Financed Healthcare Institution Kirov Center of Blood (Kirov, Russia) E-mail: kospk@yandex.ru

Relevance. The potency of raw materials, intermediate products and the finished preparation of human anti-D immunoglobulin must be determined in international units. The application of the international standard for anti-D immunoglobulin in the Russian Federation has difficulties associated with the duration of delivery and the need to comply with increased requirements for the conditions of transportation of biological thermolabile substances. In this regard, there is a need for the development of a domestic standard sample for the content of anti-D antibodies and its certification in international units. An integral step in obtaining this standard is the creation of a raw material base, taking into account the requirements for the content of anti-D antibodies in the immune blood plasma of donors. The aim of the study. To develop an algorithm for the selection of plasma donors for the production of a domestic standard sample for the anti-D antibodies content. Material and methods. The data of the information system of transfusiology for the period from january 2015 to december 2020 were analyzed about 510 donors with identified anti-erythrocyte antibodies. Immunohematological tests were performed by gel centrifugation using reagents and a set of equipment manufactured by Bio-Rad Laboratories (Switzerland). The concentration of anti-D antibodies in the blood plasma of donors was calculated in relation to the 2nd WHO international standard for anti-D immunoglobulin, NIBSC 01/572 (Great Britain). Results. It is proposed to use blood plasma of persons naturally immunized to the D-antigen as a substance for the production of a standard sample. As a result of the analysis of the requirements for the analytical range of methods for determining the potency of human anti-D immunoglobulin, it was established that the content of anti-D antibodies in the production pool of plasma for obtaining a standard sample should be at least 3.75 IU/ml. The selection of donors begins with the formation from the transfusion information system of list person with Rh-negative affiliation and identified anti-erythrocyte antibodies based on the results of a medical examination. Potential donors of anti-D plasma sent for immunohematological examination for determine the specificity of anti-erythrocyte antibodies and the content of anti-D antibodies. The presence of specific antibodies to the D-antigen is the basis for including information about the donor in the forming database. Conclusions. The necessity of creating a domestic standard sample for the content of anti-D antibodies has been proved. An algorithm for the formation of a raw material base for the production of a domestic standard sample has been developed. Using the formulated selection principles, a donor base was created, including 22 women (as of December 2020), in whose plasma the anti-D antibodies content is in the range from 0.1 to 28.5 IU/ml.

Keywords: 
donor base
anti-D antibodies
standard sample
human anti-D immunoglobulin
anti-D plasma

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Mineeva N.V., Pashkova I.A., Krobinec I.I., Sysoeva E.A. Allosensibilizacija k antigenam jeritrocitov (obzor literatury). Onkogematologija. 2015; 4(10): 60-65.
  2. Donskov S.I. Gruppy krovi sistemy Rhesus. Teorija i praktika. M.: VINITI RAN. 2005; s. 392.
  3. Vetrov V.V., Ivanov D.O., Cherminyh S.V. Zabolevaemost' gemoliticheskoj bolezn'ju novorozhdennyh pri rezus-konflikte i ee profilaktika. Problemy zhenskogo zdo-rov'ja. 2016; 3(11): 52-63.
  4. Pavlova N.G. Anti-D-immunoprofilaktika. Zhurnal akusherstva i zhenskih boleznej. 2015; 64(3): 52-57.
  5. Fox B., Sharp G., Atkinson E., Roberts G., Rigsby P., Studholme L. The third international standard for anti-D immunoglobulin: international collaborative study to evaluate candidate preparations. Vox sanguinis. 2019; 7: 740-748.
  6. Shaz B.H., Hillyer C.D., Reyes G.M. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspect, 3rd ed. Philadelphia, PA: Elsevier, 2018; p. 1048.
  7. Ozherel'eva M.A., E.N. Kravchenko, Vetrov V.V., Ivanov D.O., Kuklina L.V. Profilaktika gemoliticheskoj bolezni ploda i novorozhdennogo i ee tjazhelyh form pri rezus-konflikte (obzor literatury). Detskaja medicina Severo-Zapada. 2015; 6(3): 42-48.
  8. Ob utverzhdenii Porjadka okazanija medicinskoj pomoshhi po profilju «akusherstvo i ginekologija» (za iskljujucheniem ispol'zovanija vspomogatel'nyh reproduktivnyh tehnologij): prikaz Minzdrava Rossii ot 01.11.2012 N 572n. Dostup iz spravochno-pravovoj sistemy «Garant» (data obrashhenija: 21.08.2020).
  9. Assay of human anti-D immunoglobulin 01/2008:20713 / European Pharmacopoeia 9.0 [Jelektronnyj resurs]. URL: http://online6.edqm.eu/ep900/ (data obrashheni-ja: 21.08.2020).
  10. Prikaz Ministerstva zdravoohranenija Rossijskoj Federacii ot 09 janvarja 1998 g. № 2 «Ob utverzhdenii instrukcij po immunoserologii».
  11. Butina E.V., Mineeva N.V., Zajceva G.A, Poponina E.A, Jovdij A.V. Alloimmunizacija k antigenam jeritrocitov u pacientov s gematologicheskimi i onkogematologicheskimi zabolevanijami. Transfuziologija. 2019; 2(21): 43-46.
  12. Shvedova E.V., Kudasheva Je.Ju. Klimov V.I. Metody ocenki specificheskoj aktivnosti preparatov immunoglobulina cheloveka antirezus Rho(D): sovremennoe sostojanie problemy. Immunologija. 2020; 41(3): 256-261.